Meta-analysis of Montreal cognitive assessment diagnostic accuracy in amnestic mild cognitive impairment
- PMID: 38414877
- PMCID: PMC10896827
- DOI: 10.3389/fpsyg.2024.1369766
Meta-analysis of Montreal cognitive assessment diagnostic accuracy in amnestic mild cognitive impairment
Abstract
Background: The Montreal Cognitive Assessment (MoCA) is one of the most widely-used cognitive screening instruments and has been translated into several different languages and dialects. Although the original validation study suggested to use a cutoff of ≤26, subsequent studies have shown that lower cutoff values may yield fewer false-positive indications of cognitive impairment. The aim of this study was to summarize the diagnostic accuracy and mean difference of the MoCA when comparing cognitively unimpaired (CU) older adults to those with amnestic mild cognitive impairment (aMCI).
Methods: PubMed and EMBASE databases were searched from inception to 22 February 2022. Meta-analyses for area under the curve (AUC) and standardized mean difference (SMD) values were performed.
Results: Fifty-five observational studies that included 17,343 CU and 8,413 aMCI subjects were selected for inclusion. Thirty-nine studies were used in the AUC analysis while 44 were used in the SMD analysis. The overall AUC value was 0.84 (95% CI: 0.81, 0.87) indicating good diagnostic accuracy and a large effect size was noted for the SMD analysis (Hedge's g = 1.49, 95% CI: 1.33, 1.64). Both analyses had high levels of between-study heterogeneity. The median cutoff score for identifying aMCI was <24.
Discussion and conclusion: The MoCA has good diagnostic accuracy for detecting aMCI across several different languages. The findings of this meta-analysis also support the use of 24 as the optimal cutoff when the MoCA is used to screen for suspected cognitive impairment.
Keywords: cognitive screen; cognitively unimpaired; cutoff score; diagnostic accuracy; mild cognitive impairment.
Copyright © 2024 Malek-Ahmadi and Nikkhahmanesh.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures




Similar articles
-
Accuracy of a Self-Administered Online Cognitive Assessment in Detecting Amnestic Mild Cognitive Impairment.J Gerontol B Psychol Sci Soc Sci. 2022 Feb 3;77(2):341-350. doi: 10.1093/geronb/gbab097. J Gerontol B Psychol Sci Soc Sci. 2022. PMID: 34333629 Free PMC article.
-
Use of the Montreal Cognitive Assessment Thai Version to Discriminate Amnestic Mild Cognitive Impairment from Alzheimer's Disease and Healthy Controls: Machine Learning Results.Dement Geriatr Cogn Disord. 2021;50(2):183-194. doi: 10.1159/000517822. Epub 2021 Jul 29. Dement Geriatr Cogn Disord. 2021. PMID: 34325427
-
Validation of the Spanish-language version of the Montreal Cognitive Assessment test in adults older than 60 years.Neurologia (Engl Ed). 2019 Jul-Aug;34(6):376-385. doi: 10.1016/j.nrl.2017.01.013. Epub 2017 Mar 30. Neurologia (Engl Ed). 2019. PMID: 28364958 English, Spanish.
-
A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores.Int J Geriatr Psychiatry. 2018 Feb;33(2):379-388. doi: 10.1002/gps.4756. Epub 2017 Jul 21. Int J Geriatr Psychiatry. 2018. PMID: 28731508
-
The influence of exercise interventions on cognitive functions in patients with amnestic mild cognitive impairment: A systematic review and meta-analysis.Front Public Health. 2022 Nov 15;10:1046841. doi: 10.3389/fpubh.2022.1046841. eCollection 2022. Front Public Health. 2022. PMID: 36457329 Free PMC article.
Cited by
-
Early cognitive and quality of life changes after transfemoral transcatheter aortic valve replacement.Med Pharm Rep. 2025 Jul;98(3):311-319. doi: 10.15386/mpr-2885. Epub 2025 Jul 30. Med Pharm Rep. 2025. PMID: 40786196 Free PMC article.
-
Neurocognitive and Psychosocial Interactions in Atrial Fibrillation: Toward a Holistic Model of Care.Healthcare (Basel). 2025 Jul 30;13(15):1863. doi: 10.3390/healthcare13151863. Healthcare (Basel). 2025. PMID: 40805894 Free PMC article.
-
Comparing the Efficacy of Two Cognitive Screening Tools in Identifying Gray and White Matter Brain Damage among Older Adults.J Aging Res. 2024 Apr 23;2024:5527225. doi: 10.1155/2024/5527225. eCollection 2024. J Aging Res. 2024. PMID: 38690079 Free PMC article.
-
Short-term data suggests cognitive benefits in the elderly with single-implant overdentures.Evid Based Dent. 2024 Jun;25(2):71-72. doi: 10.1038/s41432-024-00999-4. Epub 2024 Apr 3. Evid Based Dent. 2024. PMID: 38570647 Free PMC article.
-
Association of white matter injury and neuroinflammation in the post-acute phase after ischemic stroke using [18F]FEPPA-PET/MRI.EJNMMI Res. 2025 Jul 23;15(1):91. doi: 10.1186/s13550-025-01288-6. EJNMMI Res. 2025. PMID: 40699407 Free PMC article.
References
-
- Albert M. S., DeKosky S. T., Dickson D., Dubois B., Feldman H. H., Fox N. C., et al. . (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 270–279. doi: 10.1016/j.jalz.2011.03.008, PMID: - DOI - PMC - PubMed
-
- Aycicek G. S., Çalıskan H., Ozsurekci C., Unsal P., Kessler J., Kalbe E., et al. . (2020). A reliable tool for assessing MCI and dementia: validation study of Dem Tect for Turkish population. Am. J. Alzheimers Dis. Other Dement. 35:1533317520949805. doi: 10.1177/1533317520949805 - DOI - PMC - PubMed
-
- Bello-Lepe S., Alonso-Sánchez M. F., Ortega A., Gaete M., Veliz M., Lira J., et al. . (2020). Montreal cognitive assessment as screening measure for mild and major neurocognitive disorder in a Chilean population. Dement Geriatr Cogn Dis Extra. 10, 105–114. doi: 10.1159/000506280, PMID: - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources